Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 10 studies | 31% ± 17% | |
| pericyte | 10 studies | 29% ± 14% | |
| adipocyte | 8 studies | 50% ± 13% | |
| endothelial cell of lymphatic vessel | 4 studies | 26% ± 8% | |
| smooth muscle cell | 4 studies | 23% ± 11% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| adipose | 3 studies | 24% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 1601.26 | 459 / 459 | 96% | 18.15 | 1077 / 1118 |
| lung | 100% | 1305.17 | 577 / 578 | 90% | 11.56 | 1044 / 1155 |
| intestine | 78% | 349.70 | 749 / 966 | 81% | 8.96 | 428 / 527 |
| bladder | 90% | 320.67 | 19 / 21 | 67% | 6.63 | 339 / 504 |
| adrenal gland | 99% | 901.60 | 255 / 258 | 58% | 3.61 | 134 / 230 |
| ovary | 96% | 477.27 | 172 / 180 | 60% | 5.94 | 259 / 430 |
| esophagus | 65% | 296.04 | 940 / 1445 | 86% | 12.29 | 158 / 183 |
| uterus | 97% | 473.14 | 165 / 170 | 44% | 3.68 | 202 / 459 |
| skin | 79% | 1174.57 | 1429 / 1809 | 51% | 3.00 | 240 / 472 |
| stomach | 42% | 171.02 | 152 / 359 | 86% | 9.99 | 247 / 286 |
| thymus | 97% | 443.86 | 634 / 653 | 20% | 0.90 | 119 / 605 |
| pancreas | 16% | 50.24 | 53 / 328 | 89% | 17.68 | 158 / 178 |
| adipose | 100% | 1789.45 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 90% | 473.70 | 1208 / 1335 | 0% | 0 | 0 / 0 |
| kidney | 47% | 158.90 | 42 / 89 | 32% | 1.75 | 291 / 901 |
| liver | 55% | 172.78 | 124 / 226 | 21% | 1.36 | 85 / 406 |
| prostate | 71% | 255.67 | 174 / 245 | 5% | 0.18 | 24 / 502 |
| tonsil | 0% | 0 | 0 / 0 | 56% | 6.06 | 25 / 45 |
| heart | 48% | 149.11 | 412 / 861 | 0% | 0 | 0 / 0 |
| brain | 9% | 33.76 | 238 / 2642 | 35% | 1.47 | 244 / 705 |
| spleen | 28% | 68.98 | 67 / 241 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 28% | 1.15 | 8 / 29 |
| muscle | 26% | 59.27 | 207 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 17% | 264.00 | 160 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0030167 | Biological process | proteoglycan catabolic process |
| GO_1901509 | Biological process | regulation of endothelial tube morphogenesis |
| GO_0071773 | Biological process | cellular response to BMP stimulus |
| GO_1902548 | Biological process | negative regulation of cellular response to vascular endothelial growth factor stimulus |
| GO_0007160 | Biological process | cell-matrix adhesion |
| GO_0002062 | Biological process | chondrocyte differentiation |
| GO_1902203 | Biological process | negative regulation of hepatocyte growth factor receptor signaling pathway |
| GO_0030198 | Biological process | extracellular matrix organization |
| GO_0071347 | Biological process | cellular response to interleukin-1 |
| GO_0050727 | Biological process | regulation of inflammatory response |
| GO_0032331 | Biological process | negative regulation of chondrocyte differentiation |
| GO_0071356 | Biological process | cellular response to tumor necrosis factor |
| GO_0006508 | Biological process | proteolysis |
| GO_2001113 | Biological process | negative regulation of cellular response to hepatocyte growth factor stimulus |
| GO_0030199 | Biological process | collagen fibril organization |
| GO_0051603 | Biological process | proteolysis involved in protein catabolic process |
| GO_0043931 | Biological process | ossification involved in bone maturation |
| GO_0016477 | Biological process | cell migration |
| GO_0005576 | Cellular component | extracellular region |
| GO_0031012 | Cellular component | extracellular matrix |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0004222 | Molecular function | metalloendopeptidase activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | ADAMTS12 |
| Protein name | ADAM metallopeptidase with thrombospondin type 1 motif 12 A disintegrin and metalloproteinase with thrombospondin motifs 12 (ADAM-TS 12) (ADAM-TS12) (ADAMTS-12) (EC 3.4.24.-) A disintegrin and metalloproteinase with thrombospondin motifs 12 |
| Synonyms | UNQ1918/PRO4389 |
| Description | FUNCTION: Metalloprotease that may play a role in the degradation of COMP. Cleaves also alpha-2 macroglobulin and aggregan. Has anti-tumorigenic properties. . |
| Accessions | ENST00000504830.6 [P58397-1] ENST00000515401.1 P58397 A0A0G2JRM9 ENST00000630537.2 D6REX0 ENST00000352040.7 [P58397-3] ENST00000630002.1 |
